White House Plans to Supercharge Science, But Critics Warn of Research Drought
The Trump administration is pushing a major expansion of American science while moving research funding away from universities, prompting warnings that basic research could suffer.
The Trump administration has announced an ambitious plan to greatly increase the speed and scale of scientific discovery in the United States, with officials framing the effort as a push toward a new "Golden Age of Science" [268415]. The initiative aims to accelerate innovation across multiple scientific fields and strengthen the country's position in global research and development [268415].
At the same time, U.S. science leaders are pushing back against a White House plan to shift research funding away from universities and toward private industry [263254]. They warn the move could cause a drought in basic research—the early-stage science that often leads to major breakthroughs [263254].
Basic research is the study of fundamental questions without a specific product or profit in mind, and universities have long been its main home [263254]. Science leaders argue that private companies tend to fund applied research targeting near-term commercial products, and that without universities, the pipeline of new discoveries could run dry [263254]. The White House has not announced final details of the funding plan [263254].
The administration's science push extends to specific health priorities as well. Melania Trump announced a new research and policy initiative that she said will set "a new standard for women's health" [266449]. President Donald Trump ordered the creation of a new National Institutes of Health division and a task force focused on women's health, aiming to coordinate research and policy across the federal government [266449].
The administration is also moving to allow compounding pharmacies to produce certain peptides, according to a report from STAT's Pharmalittle newsletter [264521]. Compounding pharmacies mix custom medications for individual patients, and the plan would let them make specific peptides—short chains of amino acids—that are not currently approved for general use [264521].
Separately, a new method for comparing national research systems could change how governments judge the strength of their science [266441]. The approach offers a way to measure research performance across countries and identify where improvements are needed, looking at research output, quality, and impact relative to each country's resources [266441].
The analysis suggests steps countries can take to strengthen their research systems, including better funding strategies, stronger institutions, and closer links between research and industry [266441].